Showing results (121-130 of 199) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|June 6, 2020
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM groupEnrique M Ocio, Cristina Motlló, Paula Rodríguez-Otero, et al.
The Lancet. Oncology|November 1, 2020
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trialShaji K Kumar, Simon J Harrison, Michele Cavo, et al.
Blood|July 2, 2002
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblingsAlvaro Urbano-Ispizua, Ciril Rozman, Pedro Pimentel, et al.
American Journal of Hematology|October 24, 2025
Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast NephropathyHeinz Ludwig, Meletios Athanasios Dimopoulos, Evangelos Terpos, et al.
Transfusion|March 16, 2002
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donorsJavier de la Rubia, Cristina Arbona, Felipe de Arriba, et al.
Transplantation and Cellular Therapy|February 8, 2024
Cytomegalovirus Reactivations in Allogeneic Hematopoietic Stem Cell Transplantation from HLA-Matched and Haploidentical Donors with Post-Transplantation CyclophosphamidePedro Chorão, Marta Henriques, Marta Villalba, et al.
Leukemia Research Reports|October 27, 2015
Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinationsAurelio Lopez, Maria-Victoria Mateos, Albert Oriol, et al.
Clinical Chemistry and Laboratory Medicine|November 3, 2025
Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish society of laboratory medicine and the Spanish society of hematology and hemotherapy. Part III: clinical and analytical recommendations for the study of monoclonal gammopathies by MALDI-TOF mass spectrometryCristina Agulló, Noemí Puig, Nerea Varo, et al.
Cancers|December 8, 2020
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical TrialNoemí Puig, Luis A Corchete-Sánchez, José J Pérez-Morán, et al.
Haematologica|April 22, 2006
Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) StudyJavier de la Rubia, Joan Bladé, Juan-José Lahuerta, et al.
Pageof 20